These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 24467717)

  • 1. Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review.
    Patnaik MM; Parikh SA; Hanson CA; Tefferi A
    Br J Haematol; 2014 May; 165(3):273-86. PubMed ID: 24467717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
    Patnaik MM; Tefferi A
    Mayo Clin Proc; 2016 Feb; 91(2):259-72. PubMed ID: 26848006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.
    McCullough KB; Patnaik MM
    Curr Hematol Malig Rep; 2015 Sep; 10(3):292-302. PubMed ID: 26122388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.
    Bacher U; Haferlach T; Schnittger S; Kreipe H; Kröger N
    Br J Haematol; 2011 Apr; 153(2):149-67. PubMed ID: 21401573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2018 Jun; 93(6):824-840. PubMed ID: 29878489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of patients with chronic myelomonocytic leukemia.
    Alfonso A; Montalban-Bravo G; Garcia-Manero G
    Curr Opin Oncol; 2017 Jan; 29(1):79-87. PubMed ID: 27849645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2016 Jun; 91(6):631-42. PubMed ID: 27185207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2020 Jan; 95(1):97-115. PubMed ID: 31736132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myelomonocytic leukemia - a review.
    Thomopoulos TP; Bouhla A; Papageorgiou SG; Pappa V
    Expert Rev Hematol; 2021 Jan; 14(1):59-77. PubMed ID: 33275852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myelomonocytic leukemia: myeloproliferative variant.
    Onida F; Beran M
    Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y; Harada H
    Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2013 Nov; 88(11):967-74. PubMed ID: 23963888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current management of patients with chronic myelomonocytic leukemia.
    Mora E; Sanz GF
    Curr Opin Oncol; 2018 Nov; 30(6):409-417. PubMed ID: 30169461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment.
    Elmariah H; DeZern AE
    Curr Hematol Malig Rep; 2019 Jun; 14(3):154-163. PubMed ID: 31093889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.
    Patnaik MM; Tefferi A
    Blood Cancer J; 2016 Feb; 6(2):e393. PubMed ID: 26849014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2024 Jun; 99(6):1142-1165. PubMed ID: 38450850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.
    Coltro G; Patnaik MM
    Curr Oncol Rep; 2019 Nov; 21(11):101. PubMed ID: 31728739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelomonocytic leukemia prognostic classification and management: evidence base and current practice.
    Selimoglu-Buet D; Solary E
    Curr Hematol Malig Rep; 2014 Dec; 9(4):301-10. PubMed ID: 25142910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.
    Padron E; Steensma DP
    Curr Opin Hematol; 2015 Mar; 22(2):163-70. PubMed ID: 25575034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.